An­oth­er Eli Lil­ly on­col­o­gy drug is in trou­ble, as Japan is­sues Verzenio safe­ty warn­ing

Eli Lil­ly is in trou­ble, again. This year, a late-stage fail­ure prompt­ed the with­draw­al of its can­cer drug Lartru­vo; its erec­tile dys­func­tion treat­ment Cialis is be­ing eat­en up by gener­ic com­pe­ti­tion; and in the first quar­ter, the US drug­mak­er rel­e­gat­ed two mid-stage drugs to the scrap heap. Now, re­ports have emerged that Japan has flagged safe­ty con­cerns as­so­ci­at­ed with its breast can­cer treat­ment, Verzenio.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.